Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline plus nicotine lozenges for smoking cessation in hospitalized adults
ACTRN12618001792213Phase 4Completed
- Sponsor
- Monash University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in nicotine dependence comparing Varenicline + nicotine lozenges with Varenicline + placebo lozenges (2 arms). Primary endpoint: Primary: CO-verified continuous abstinence. Started May 2019; status: completed.
02
Drugs
vareniclinenicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12618001792213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001792213.